Course Provider
Learning Objectives
Upon completion of this activity, participants should be better able to assess the underlying etiology and pathophysiology of SMA, including SMA subtypes and connection to clinical manifestations in adults, to support early recognition of signs/symptoms and prompt, accurate diagnosis in this age cohort
Upon completion of this activity, participants should be better able to describe the unique clinical and psychosocial burden of SMA in adult patients
Upon completion of this activity, participants should be better able to differentiate new and emerging treatment approaches for adults with SMA, including disease-modifying agents, based on their efficacy and safety data and mechanism of action, and the importance of treatment
Upon completion of this activity, participants should be better able to align clinical practices with current evidence, guideline recommendations, and patient-specific characteristics, goals, and preferences to develop personalized, risk-informed treatment and monitoring plans
Upon completion of this activity, participants should be better able to integrate effective strategies for engagement and shared decision-making with adult SMA patients, timely referrals, and multidisciplinary care to optimize treatment outcomes and quality of life